Comparison of efficacy of intralesional 5-fluorouracil and cryotherapy in the treatment of common and palmoplantar warts
Phase 3
Not yet recruiting
- Conditions
- Condition 1: palmoplantar wart. Condition 2: Common wart.Plantar wartOther viral wartsB07.0B07.8
- Registration Number
- IRCT20140212016557N6
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients of 16 years of age and higher
Common type warts
Palmoplantar type warts
Exclusion Criteria
Patients with more than 5 lesions
Pregnancy
Lactation
Patients with vascular, cardiovascular, hepatic, and chronic kidney disease
Patients with hypersensitivity to 5-flurouracil, lidocaine, epinephrine, or cryotherapy
Beta-blocker drug consumption
Immunocompromised patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete clinical cure. Timepoint: At the beginning of treatment, and weeks 1, 2, 3, 4, 5, 6, 8, and 14. Method of measurement: Lesion size calculation by ruler and dermatoscopy.
- Secondary Outcome Measures
Name Time Method Pain during treatment. Timepoint: Weeks 1, 2, 3, 4, 5, 6. Method of measurement: Pain illustrated numerical rating scale.;Quality of life. Timepoint: At the beginning of treatment, and the end of treatment. Method of measurement: Dermatology quality of life index Persian version.